Global Point-Of-Care Or Rapid Diagnostics Market Size, Share, Trends and Forecast 2022-2030

Description

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.

Industry Insights

Due to the COVID-19 pandemic, the global Point-Of-Care Or Rapid Diagnostics market size is estimated to be worth US$ 25670 million in 2021 and is forecast to a readjusted size of US$ 48500 million by 2028 with a CAGR of 9.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Point-Of-Care Or Rapid Diagnostics market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Point-Of-Care Or Rapid Diagnostics landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.

In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.

This report focuses on Point-Of-Care Or Rapid Diagnostics volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Point-Of-Care Or Rapid Diagnostics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Point-Of-Care Or Rapid Diagnostics market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Intensive Care

Covid-19 Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Others

Segment by Application

Hospital

Clinic

Independent Laboratories

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche

Abbott

Danaher

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Nova Biomedical

Thermo Fisher Scientific

Quidel

A. Menarini Diagnostics

Becton Dickinson

Biosurfit

Astrego Diagnostics

Werfen

Abionic

Palex Medical/Bülhmann

Horiba Medical

RAL

Vircell

Monlab

Binding Site

TABLE OF CONTENT

1 Point-Of-Care Or Rapid Diagnostics Market Overview
1.1 Product Overview and Scope of Point-Of-Care Or Rapid Diagnostics

1.2 Point-Of-Care Or Rapid Diagnostics Segment by Type

1.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Intensive Care

1.2.3 Covid-19 Testing

1.2.4 Infectious Diseases Testing

1.2.5 Cardiac Markers Testing

1.2.6 Coagulation Testing

1.2.7 Others

1.3 Point-Of-Care Or Rapid Diagnostics Segment by Application

1.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Comparison by Application: (2022-2028)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Independent Laboratories

1.3.5 Others

1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size Estimates and Forecasts

1.4.1 Global Point-Of-Care Or Rapid Diagnostics Revenue 2017-2028

1.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales 2017-2028

1.4.3 Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2017 Versus 2021 Versus 2028

2 Point-Of-Care Or Rapid Diagnostics Market Competition by Manufacturers

2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2017-2022)

2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Point-Of-Care Or Rapid Diagnostics Manufacturing Sites, Area Served, Product Type

2.5 Point-Of-Care Or Rapid Diagnostics Market Competitive Situation and Trends

2.5.1 Point-Of-Care Or Rapid Diagnostics Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue

2.5.3 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario by Region

3.1 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country

3.3.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Country

3.3.2 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country

3.4.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country

3.4.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Region

3.5.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region

3.5.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country

3.6.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country

3.6.2 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country

3.7.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country

3.7.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Type

4.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)

4.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2017-2022)

4.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2017-2022)

5 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Application

5.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)

5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2017-2022)

5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Abbott

6.2.1 Abbott Corporation Information

6.2.2 Abbott Description and Business Overview

6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.2.5 Abbott Recent Developments/Updates

6.3 Danaher

6.3.1 Danaher Corporation Information

6.3.2 Danaher Description and Business Overview

6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.3.5 Danaher Recent Developments/Updates

6.4 Siemens Healthcare

6.4.1 Siemens Healthcare Corporation Information

6.4.2 Siemens Healthcare Description and Business Overview

6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.4.5 Siemens Healthcare Recent Developments/Updates

6.5 Bio-Rad Laboratories

6.5.1 Bio-Rad Laboratories Corporation Information

6.5.2 Bio-Rad Laboratories Description and Business Overview

6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.5.5 Bio-Rad Laboratories Recent Developments/Updates

6.6 BioMerieux

6.6.1 BioMerieux Corporation Information

6.6.2 BioMerieux Description and Business Overview

6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.6.5 BioMerieux Recent Developments/Updates

6.7 Nova Biomedical

6.6.1 Nova Biomedical Corporation Information

6.6.2 Nova Biomedical Description and Business Overview

6.6.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.7.5 Nova Biomedical Recent Developments/Updates

6.8 Thermo Fisher Scientific

6.8.1 Thermo Fisher Scientific Corporation Information

6.8.2 Thermo Fisher Scientific Description and Business Overview

6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.8.5 Thermo Fisher Scientific Recent Developments/Updates

6.9 Quidel

6.9.1 Quidel Corporation Information

6.9.2 Quidel Description and Business Overview

6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.9.5 Quidel Recent Developments/Updates

6.10 A. Menarini Diagnostics

6.10.1 A. Menarini Diagnostics Corporation Information

6.10.2 A. Menarini Diagnostics Description and Business Overview

6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.10.5 A. Menarini Diagnostics Recent Developments/Updates

6.11 Becton Dickinson

6.11.1 Becton Dickinson Corporation Information

6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.11.5 Becton Dickinson Recent Developments/Updates

6.12 Biosurfit

6.12.1 Biosurfit Corporation Information

6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.12.5 Biosurfit Recent Developments/Updates

6.13 Astrego Diagnostics

6.13.1 Astrego Diagnostics Corporation Information

6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.13.5 Astrego Diagnostics Recent Developments/Updates

6.14 Werfen

6.14.1 Werfen Corporation Information

6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.14.5 Werfen Recent Developments/Updates

6.15 Abionic

6.15.1 Abionic Corporation Information

6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.15.5 Abionic Recent Developments/Updates

6.16 Palex Medical/Bülhmann

6.16.1 Palex Medical/Bülhmann Corporation Information

6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.16.5 Palex Medical/Bülhmann Recent Developments/Updates

6.17 Horiba Medical

6.17.1 Horiba Medical Corporation Information

6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.17.5 Horiba Medical Recent Developments/Updates

6.18 RAL

6.18.1 RAL Corporation Information

6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.18.5 RAL Recent Developments/Updates

6.19 Vircell

6.19.1 Vircell Corporation Information

6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.19.5 Vircell Recent Developments/Updates

6.20 Monlab

6.20.1 Monlab Corporation Information

6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.20.5 Monlab Recent Developments/Updates

6.21 Binding Site

6.21.1 Binding Site Corporation Information

6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Description and Business Overview

6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2017-2022)

6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio

6.21.5 Binding Site Recent Developments/Updates

7 Point-Of-Care Or Rapid Diagnostics Manufacturing Cost Analysis

7.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics

7.4 Point-Of-Care Or Rapid Diagnostics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Point-Of-Care Or Rapid Diagnostics Distributors List

8.3 Point-Of-Care Or Rapid Diagnostics Customers

9 Point-Of-Care Or Rapid Diagnostics Market Dynamics

9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends

9.2 Point-Of-Care Or Rapid Diagnostics Market Drivers

9.3 Point-Of-Care Or Rapid Diagnostics Market Challenges

9.4 Point-Of-Care Or Rapid Diagnostics Market Restraints

10 Global Market Forecast

10.1 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Type (2023-2028)

10.2 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Application (2023-2028)

10.3 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample